- Home
- PSNL vs AVAH Comparison
PSNL vs AVAH Comparison
Compare PSNL & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNL | AVAH |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSNL | AVAH |
|---|---|---|
| Price | $14.16 | $9.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $12.20 | $9.75 |
| AVG Volume (30 Days) | ★ 4.7M | 1.9M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.58 | ★ 1850.00 |
| EPS | N/A | ★ 0.19 |
| Revenue | $69,648,000.00 | ★ $2,433,199,000.00 |
| Revenue This Year | $15.34 | $7.31 |
| Revenue Next Year | $41.46 | $5.59 |
| P/E Ratio | ★ N/A | $49.00 |
| Revenue Growth | N/A | ★ 20.19 |
| 52 Week Low | $4.43 | $5.93 |
| 52 Week High | $16.39 | $10.32 |
Technical Indicators
Market Signals| Indicator | PSNL | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 51.25 |
| Support Level | $6.68 | $8.89 |
| Resistance Level | $16.39 | $9.89 |
| Average True Range (ATR) | 0.75 | 0.32 |
| MACD | -0.08 | -0.11 |
| Stochastic Oscillator | 46.75 | 31.00 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.